Replimune Group REPL Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Replimune Group's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Replimune Group's common stock, shares issued (in shares)?
- Replimune Group (REPL) reported common stock, shares issued (in shares) of $79.63M in Q4 2025.
- How has Replimune Group's common stock, shares issued (in shares) changed year-over-year?
- Replimune Group's common stock, shares issued (in shares) increased by 3.4% year-over-year, from $77.01M to $79.63M.
- What is the long-term trend for Replimune Group's common stock, shares issued (in shares)?
- Over 4 years (2021 to 2025), Replimune Group's common stock, shares issued (in shares) has grown at a 13.4% compound annual growth rate (CAGR), from $46.57M to $77.09M.